Cargando…

Sublobectomy for stage IA1‐2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25

BACKGROUND: Sublobectomy for early‐stage non‐small cell lung cancer (NSCLC) remains a matter of debate. This study aimed to discuss the feasibility of sublobectomy in patients with pathological‐stage IA1‐2 confirmed as pathologically invasive but radiologically noninvasive adenocarcinoma. METHODS: F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yi‐Fan, Qiu, Zhen‐Bin, Zhang, Chao, Fu, Rui, Yang, Xiong‐Wen, Chu, Xiang‐Peng, Chen, Zi‐Hao, Yang, Xue‐Ning, Wu, Yi‐Long, Zhong, Wen‐Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663678/ https://www.ncbi.nlm.nih.gov/pubmed/36208139 http://dx.doi.org/10.1111/1759-7714.14672

Ejemplares similares

Functional Preserving Sublobectomy: A Novel Method for Sublobectomy
por: Zhang, Min, et al.
Publicado: (2021)

Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25
por: Isaka, Tetsuya, et al.
Publicado: (2023)

A Comparative Study of 0.25% Levobupivacaine, 0.25% Ropivacaine, and 0.25% Bupivacaine in Paediatric Single Shot Caudal Block
por: Sharma, Jagdeep, et al.
Publicado: (2018)

V7 ENB‐guided thoracoscopic sublobectomy for stage IA synchronous multiple primary lung cancer
por: Wang, Kun, et al.
Publicado: (2022)

Evaluation of Photocatalytic Performance of Nano-Sized Sr(0.9)La(0.1)TiO(3) and Sr(0.25)Ca(0.25)Na(0.25)Pr(0.25)TiO(3) Ceramic Powders for Water Purification
por: Jovanoski Kostić, Aleksandra, et al.
Publicado: (2022)

Clinical analysis of the impact of sublobectomy on pulmonary function
por: Yang, Haiping, et al.
Publicado: (2017)

Sublobectomy versus Lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study
por: Liu, Yaxin, et al.
Publicado: (2014)

Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy
por: Wo, Yang, et al.
Publicado: (2019)

Caudal Epidural Analgesia in Pediatric Patients: Comparison of 0.25% Levobupivacaine and 0.25% Ropivacaine in Terms of Motor Blockade and Postoperative Analgesia
por: Praveen, P., et al.
Publicado: (2017)

Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

A Comparative Study of Effect of 0.25% Levobupivacaine with Dexmedetomidine versus 0.25% Levobupivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block
por: Iyer, Lakshmi S., et al.
Publicado: (2021)

Exchange-bias via nanosegregation in novel Fe(2−x)Mn(1+x)Al (x = −0.25, 0, 0.25) Heusler films
por: Kurdi, S., et al.
Publicado: (2020)

Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
por: Yang, Yong, et al.
Publicado: (2021)

Peculiar Properties of the La(0.25)Ba(0.25)Sr(0.5)Co(0.8)Fe(0.2)O(3−δ) Perovskite as Oxygen Reduction Electrocatalyst
por: Aliotta, Chiara, et al.
Publicado: (2023)

Potential outstanding physical properties of novel black arsenic phosphorus As(0.25)P(0.75)/As(0.75)P(0.25) phases: a first-principles investigation
por: Liu, Fangqi, et al.
Publicado: (2022)

KNb(1.75)V(0.25)PS(10)
por: Yu, Jaemin, et al.
Publicado: (2011)

Treatment of angiokeratomas of Fordyce with topical rapamycin 0.25% cream
por: Bell, Katheryn A., et al.
Publicado: (2020)

Correction to: Lotilaner Ophthalmic Solution 0.25%: First Approval
por: Syed, Yahiya Y.
Publicado: (2023)

A Nomogram Based on Consolidation Tumor Ratio Combined with Solid or Micropapillary Patterns for Postoperative Recurrence in Pathological Stage IA Lung Adenocarcinoma
por: Zhang, Longfu, et al.
Publicado: (2023)

Reappraising the clinical usability of consolidation-to-tumor ratio on CT in clinical stage IA lung cancer
por: Yoon, Dong Woog, et al.
Publicado: (2022)

The CMS tracker APV25 $0.25 \mu m$ CMOS readout chip
por: Raymond, M, et al.
Publicado: (2000)

Arthroscopic and Low-Field MRI (0.25 T) Evaluation of Meniscus and Ligaments of Painful Knee
por: Lokannavar, Harish S, et al.
Publicado: (2012)

1-Benzyl-3-methylimidazolium chloride 0.25-hydrate
por: Ji, Xiujie, et al.
Publicado: (2009)

Possible quadrupole-first options with $\beta^* \leq$ 0.25M
por: Koutchouk, Jean-Pierre
Publicado: (2006)

Standard of Spectral Radiance for the Region of 0.25 to 2.6 Microns
por: Stair, Ralph, et al.
Publicado: (1960)

Experiments on MEMS Integration in 0.25 μm CMOS Process
por: Michalik, Piotr, et al.
Publicado: (2018)

Cataract Surgery by Intraoperative Surface Irrigation with 0.25% Povidone–Iodine
por: Shimada, Hiroyuki, et al.
Publicado: (2021)

Effect of Al-5Ti-0.25C-0.25B and Al-5Ti-1B Master Alloys on the Microstructure and Mechanical Properties of Al-9.5Si-1.5Cu-0.8Mn-0.6Mg Alloy
por: Wen, Yihan, et al.
Publicado: (2023)

4-(3-Methylanilino)-N-[N-(1-methylethyl)carbamoyl]pyridinium-3-sulfonamidate (torasemide) methanol 0.25-solvate 0.25-hydrate
por: Bartolucci, Gianluca, et al.
Publicado: (2009)

Ultrasound guided peritubal infiltration of 0.25% Bupivacaine versus 0.25% Ropivacaine for postoperative pain relief after percutaneous nephrolithotomy: A prospective double blind randomized study
por: Parikh, Geeta P, et al.
Publicado: (2014)

Enhancing the photocatalytic activity of Cu(0.25)Zn(0.75)S nanodisks by metallic Ag loading in the visible-light region
por: Zhang, Jinyang, et al.
Publicado: (2019)

Wall-plug power of 2x0.25 TeV CLIC
por: Hübner, K
Publicado: (1992)

3,4-Dinitro-1H-pyrazole benzene 0.25-solvate
por: Li, Yong-Xiang, et al.
Publicado: (2011)

2,3,4-Trihydroxybenzoic acid 0.25-hydrate
por: Li, Jin-Hang, et al.
Publicado: (2012)

Wall-plug power of 2x0.25 TeV CLIC
por: Hübner, K
Publicado: (1992)

Design of a comparator in a 0.25 $\mu m$ CMOS technology
por: Van Bakel, N, et al.
Publicado: (2000)

The 0.25um Token Bit Manager Chip for the CMS Pixel Readout
por: Bartz, Edward
Publicado: (2005)

Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia: A Pilot, Randomized Open-Label Study
por: Bharadwaj, Apoorva V, et al.
Publicado: (2023)

Alfentanil-bupivacaina al 0.125 % vs. bupivacaina al 0.25 % en analgesia obstétrica.
por: Santiago Poot, Noemi
Publicado: (1994)

Bupivacaina al 0.25 versus 0.125% para analgesia obstétrica en pacientes primigestas
por: Reyes González, Rosa Isela
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_mni7iv1uknfp2a7p4bvb0i0elo